Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

A Phase I Study in Asthma Patients Evaluating the Effect of Doses of FlutiForm™ on the Amount, if Any, of Cortisol Produced by the Adrenal Glands

ClinicalTrials.gov ID: NCT00657774

Public ClinicalTrials.gov record NCT00657774. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 2:21 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel Group, 6-Week Study to Evaluate the Effect of Multiple Doses of FlutiForm™ 250/10 Microgram HFA pMDI Twice Daily, FlutiForm™ 100/10 Microgram HFA pMDI Twice Daily, Prednisone and Placebo on the Hypothalmic-Pituitary-Adrenal Axis in Adult Subjects With Mild to Moderate Asthma.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The medications being used in this study are individually approved by the Food and Drug Administration (FDA). The medication under investigation is a combination of the two medications in one inhaler. The purpose of the study is to determine how the medication affects the amount, if any, of cortisol produced by the adrenal glands.

Study identification

NCT ID
NCT00657774
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
SkyePharma AG
Industry
Enrollment
160 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2008 (Type not available)
Primary completion
Sep 2008 (Actual)
Completion
Sep 2008 (Actual)
Last update posted
Dec 1, 2008

2008

United States locations

U.S. sites
19
U.S. states
11
U.S. cities
19
Facility City State ZIP Site status
Investigational site Phoenix Arizona 85006 —
Investigational site Anaheim California 92801 —
Investigational site Long Beach California 90806 —
Investigational site San Diego California 92120 —
Investigational site Centennial Colorado 80112 —
Investigational site Colorado Springs Colorado 80907 —
Investigational site Denver Colorado 80206 —
Investigational site Lakewood Colorado 80401 —
Investigational site DeLand Florida 32720 —
Investigational Site Pasadena Maryland 21122 —
Investigational site North Dartmouth Massachusetts 02747 —
Investigational site Omaha Nebraska 68154 —
Investigational site Skillman New Jersey 08558 —
Investigational Site Lake Oswego Oregon 97035 —
Investigational site Portland Oregon 97213 —
Investigational site Spartanburg South Carolina 29303 —
Investigational site El Paso Texas 79902 —
Investigational site New Braunfels Texas 78130 —
Investigational site San Antonio Texas 78229 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00657774, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 1, 2008 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00657774 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →